Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic Portfolio Corporate NewsBy adminNovember 28, 2023
Equinox Pharma Holding Limited (Equinox) increases stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Corporate NewsBy adminNovember 6, 2023
Disclosure to EGX regarding BOD and shareholding structure Regulatory DisclosuresBy adminOctober 8, 2023
Disclosure to EGX regarding the appointment of Khaled Daader as Head of Investor Relations and Mergers and Acquisitions Regulatory DisclosuresBy adminOctober 2, 2023
Disclosure to EGX regarding stock dividend distribution Regulatory DisclosuresBy adminSeptember 4, 2023
